In microarray gene expression experiments, several diverse conditions in each experiment (e.g., time, doses, replicates) increase the data points from tens of thousands of measurements for a single ...

SAN DIEGO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO) today announced the release of the latest versions of its VIA™ and Solve™ software for genomic data analysis and ...

Microarray technology allows the simultaneous monitoring of expression levels of thousands of genes and even whole genomes. But the experiments themselves represent only the opening act. The grand ...

A single microarray experiment provides thousands of individual pieces of data; it is therefore essential to focus on effective informatics methods in order to draw new biological conclusions ...

Microarray data is to gene expression what genomic sequences are to molecular biology—a wonderful collection of information to have, but where, or how, does one start analyzing it? Fortunately, the ...

CARLSBAD, Calif.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, announced today that the Applied Biosystems™ CytoScan™ Dx Assay and Applied Biosystems™ ...

Array-Pro Analyzer Version 6.3 image analysis software is designed for molecular biologists, this microarray and high-density array software provides tools to achieve maximum signal to noise, ...

We have previously published a suite of software tools that facilitates the reformulation of tissue microarray (TMA) data so that it may be analyzed using techniques originally devised for analysis of ...

Dartmouth Institute for Quantitative Biomedical Sciences (iQBS) researchers developed a new gene expression analysis approach for identifying cancer genes. The paper entitled, "How to get the most ...

BUFFALO, N.Y. -- A multidisciplinary team of pharmaceutics and computer-science researchers at the University at Buffalo, one of very few teams in the nation applying DNA microarray technology in ...

Preliminary safety results of an ongoing phase I/II clinical study of MGN1601, a tumor vaccine comprising allogeneic, gene-modified, and irradiated tumor cells in combination with an immunomodulator ...